[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dysimmune-dermatological-diseases\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dysimmune-dermatological-diseases":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100545879","clinico-biological-collection-of-autoimmune-dysimmune-or-auto-inflammatory-dermatological-diseases-100545879",false,"NCT06387654","Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases","Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Physiopathological Investigations of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases","TekAPo","Inclusion Criteria:\n\nSkin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin.\n\nThe patients included may be adults or children, and will be:\n\n* Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others),\n* Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example),\n* Patients with cutaneous lupus\n* Patients with dysimmune skin diseases (psoriasis, eczema)\n* Patients with immuno-induced dermatological disorders or drug dermatitis\n* Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.).\n\nPatients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected\n\nExclusion Criteria:\n\n* Patients under protective supervision (guardianship, curators)\n* Patients under 6 years old\n* Pregnant or breastfeeding woman","ALL","6 Years","99 Years",{"count":21,"type":22},800,"ESTIMATED","OBSERVATIONAL","The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.",[26,27,28,29],"Autoimmune Bullous Dermatosis","Dysimmune Dermatological Diseases","Auto-inflammatory Dermatological Diseases","Skin Diseases",[31,32,33,34,35,36,37],"auto-inflammatory dermatological diseases","Cutaneous lupus","scleroderma","dermatomyositis","psoriasis","eczema","new therapies","RECRUITING","2026-03-16",{"date":41,"type":42},"2026-03-17","ACTUAL",{"date":44,"type":42},"2024-05-06",{"date":46,"type":22},"2034-04",{"name":48,"class":49},"University Hospital, Toulouse","OTHER"]